Rosiglitazone Restores Renal Dopamine Receptor Function in Hyperinsulinemic Rats
A study of obese hyperinsulinemic rats that exhibit defective dopamine receptor function in the proximal tubules shows that rosiglitazone reverses this defect, researchers at the
